Nigeria’s pharmaceutical manufacturers are finally seeing a silver lining in their balance sheets, but for the average patient at the pharmacy counter, the relief remains invisible. While federal tax waivers have successfully padded the profit margins of local drugmakers, retail medicine prices co
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
